ABSTRACT
Objective Pelvic radiotherapy (RT) often results in toxicity to the gastrointestinal tract and clinical trials have demonstrated a potentially beneficial role of dietary supplements in overcoming this problem, mainly acute effects. This systematic review and meta-analysis were undertaken with the aim of evaluating the efficacy of several dietary supplement interventions in preventing or alleviating symptoms of gastrointestinal toxicity in patients undergoing RT for a range of common pelvic malignancies.
Design The search protocol was prospectively submitted to PROSPERO at the University of York. CENTRAL, MEDLINE, EMBASE, and http://ClinicalTrials.gov were searched up to June 2020 for randomised controlled clinical trials. Interventions included four supplement categories: biotics, amino acids, poly-unsaturated fatty acids and polyphenols. Efficacy was determined with reference to outcomes based on symptoms of acute gastrointestinal toxicity, including diarrhoea, nausea and vomiting.
Results Twenty-three randomised controlled trials (1919 patients) were identified in this review. Compared with placebo, probiotics, synbiotics and polyphenols were significantly associated with a lower risk of diarrhoea. Biotic supplements also reduced the risk of moderate to severe diarrhoea and the need for anti-diarrhoeal medication. In contrast, amino acid supplements had no effect on acute symptoms. There was a non-significant trend for reduction in nausea and mean bowel movements per day using dietary supplements.
Conclusions Biotic supplements, especially probiotics and synbiotics, reduce acute symptoms of gastrointestinal toxicity in patients undergoing pelvic radiotherapy. More randomised placebo-controlled studies with larger numbers of patients are needed to define specific formulations for supplement interventions that will be of greatest benefit to patients.
What is already known about this subject?Clinical trials have indicated a potentially beneficial role of dietary supplements for the prevention and treatment of radiation-induced gastrointestinal symptoms.
What are the new findings?In this systematic review, we found biotics and polyphenols can significantly reduce the risk of diarrhoea, while biotics were also associated with a lower incidence of moderate to severe diarrhoea and anti-diarrhoeal medication use. Among biotic supplements, both synbiotics and probiotics were found to be potentially beneficial in the prevention of diarrhoea.
How might it impact on clinical practice in the foreseeable future?Cancer patients undergoing pelvic RT may benefit from taking biotic supplements for alleviation of gastrointestinal toxicity symptoms following pelvic radiation. More randomised controlled trials are required to determine the optimum formulations and combinations.
Trial registration number The study protocol was published on the PROSPERO international prospective register of systematic reviews (registration number CRD42020183304).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by Cancer Research UK Programme grant C5255/A23755. The funding body had no role in the design of the study, collection, analysis, interpretation of data or in writing the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
N/A
